Global genomic therapies market sales to hit $89.8b by 2030

The sector is primarily driven by gene therapies.

The global genomic therapies market sales are projected to reach $89.8b by 2030 at a compound annual growth rate of 28.3%, according to GlobalData.

The sector’s expansion is primarily driven by gene therapies, which generated $2.6b in sales in 2024 and are expected to hit $30.9b during the forecast period.

The growth of gene therapies is attributed to technological advancements such as artificial intelligence and machine learning, said Gaffar Aga, Strategic Intelligence Analyst at GlobalData.

These advancements support large genomic datasets and accelerate drug discovery and development, Aga added.